Published Date : 2025-Apr-21
The global guidewires market is driven by rising cardiovascular procedures, technological advancement in interventional techniques, and minimally invasive surgeries.
The market is poised to grow US$ 1.69 billion by 2032, growing at a CAGR of 3% in the forecast period (2024-2032).
Leading players are Boston Scientific Corporation, Terumo Corporation, Medtronic, Abbott Laboratories, B Braun, Cardinal Health, Cook Medical, Olympus Corporation, Merit Medical Systems And More.
Global Guidewires Market Size, Share & Trends Analysis Report By Type (Traditional Guidewires, Hydrophilic Guidewires, Drug-Coated Guidewires, Bioengineered Guidewires), By Material (Stainless Steel Guidewires, Nitinol Guidewires), By Application (Cardiovascular, Neurovascular, Peripheral Vascular, Urology, Gastrointestinal), By End-User (Hospitals, Ambulatory Surgical Centres (ASCs), Clinics) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) | Forecast [2024-2032].
According to a new report by IMIR Market Research on Global Guidewires Market size was valued at USD 1.3 Billion in 2023 and is poised to grow USD 1.69 Billion by 2032, growing at a CAGR of 3% in the forecast period (2024-2032).
In the context of the present report, the guidewires market stands for the global industry concerned with the production, distribution, and use of guidewires, the thin, flexible wires designed to be guided through anatomical structures in the course of minimally invasive medical procedures. These wires play a crucial role in guiding larger devices such as catheters, stents, or balloons to particular treatment sites inside the human body.
Growth in the industry of guidewires is generally attributed to urological disorders, peripheral artery disease (PAD), and cardiovascular diseases (CVD). For example, the PCR online states that the main cause of death for women and men alike are CVD. In 2023, the world has a population of 8.0 billion, where 620.0 million individuals are suffering from heart and circulatory diseases. Around 60.0 million people globally suffer from heart or circulatory diseases every year.
angina pectoris, one of the most common causes of morbidity and mortality around the world, is a serious condition that many people suffer from. For example, the National Library of Medicine states that, in 2024, angina pectoris prevalence globally was between around 2.0% and 7.0%. More than 2,806,000 cases of angina pectoris were also reported in China in 2023. There is a proof that angina doubles the risk of major cardiovascular events. In the present scenario, CAD contributes to 4.1 million deaths in Europe every year. Among these, 82.0% are people above 65 years. The increasing number of minimally invasive surgeries is the main factors driving the guidewires market.
For example, according to the February 2022 NCBI published study, a total of approximately 57.0% patient’s selected minimally invasive treatment decided to do it because healthcare workers who recommended and supported this mode of treatment considered this treatment useful for them. Both healthcare practitioners and patients appear to be increasingly biased towards non-invasive modalities than those of conventional method. Hence, an increase in the adoption of minimally invasive procedures may positively influence market growth. Moreover, the Far North Surgery report released in March 2024 suggests that the demand for minimally invasive procedures will continue to grow substantially and may reach more than 44.0 billion by the year 2030, showing a trend of less invasive medical interventions in the coming years. One of the most significant factors for increasing the use of guide wire is technological advancement.
The advanced guidewires can be tailored according to the need and can be used from a distance. This, in turn, increases the success rate of the procedures, which ultimately increases the overall adoption rate of minimally invasive surgeries. These guidewires, along with imaging modalities and surgical robots, have limitless applications in the modern practice of surgery. For example, in April 2024, Teleflex Incorporated launched the Wattson Temporary Pacing Guide wire, designed uniquely for use in Balloon Aortic Valvuloplasty (BAV) and Trans catheter aortic valve replacement (TAVR). The guide wire has the features of supporting valve delivery, dual functionality, and ventricular bipolar pacing. It is expected to streamline procedural efficiencies and reduce complications as compared with traditional methods. Additionally, the current studies are in progression, which contribute to market growth.
For example, in April 2022, MicroVention, Inc., a subsidiary of Terumo Corporation, completed the first enrolment in a multicentre, prospective EU observational study called STRAIT (Safety and Efficacy Study of the Traxcess EX Guidewire and Other Vascular Devices in the Treatment of Intracranial Aneurysms), to evaluate the safety and efficacy of the Traxcess EX Guidewire and other vascular devices in the treatment of intracranial aneurysms. The rising geriatric population further accelerates the market growth.
For example, according to WHO, by 2030, 1 in 6 people would be 60 years of age or older. The same demographic will double by 2050. Furthermore, diseases are much more prevalent among elderly people. Such diseases include cardiovascular disease, ischemic heart disease, vascular dementia, and multiple sclerosis, to name a few. According to the National Centre for Health Statistics, in 2020, 6.3% of adults aged 18 years and over had diagnosed heart disease in the U.S. This estimate is based on household interviews of a sample of the civilian, no institutionalized U.S. population.
Founded: 1979
Headquarters: Marlborough, Massachusetts, USA
Employees: Approx. 45,000
2024 Revenue: $14.2 Billion
Regions Dominated: North America, Europe, Asia-Pacific
Boston Scientific is a global leader in interventional technologies, particularly in the guidewire sector. The company develops advanced guidewires tailored for Cardiovascular interventions, Peripheral artery disease, Neurovascular procedures, Endoscopic procedures and more.
Flagship Guidewire Brands: Platinum Plus™ – Designed for percutaneous coronary interventions (PCI), Fathom™ – Known for neurovascular navigation, Jagwire™ – ERCP guidewire for endoscopy.
Boston Scientific has committed to — Net-zero carbon emissions by 2050.
Founded: 1921
Headquarters: Tokyo, Japan
Employees: Approx. 30,000
2024 Revenue: $6.4 Billion
Regions Dominated: Asia, EU, LATAM
Terumo is a pioneer in interventional guidewire, especially guidewires used for vascular access, cardiology, and neurovascular surgery. Their products are known for high reliability, hydrophilic coatings, and superior maneuverability.
Notable Guidewire Brands:
Terumo has committed to — Carbon-neutral by 2040.
Founded: 1949
Headquarters: Dublin, Ireland (Operational HQ: Minneapolis, USA)
Employees: Approx. 95,000
2024 Revenue: $31 Billion
Regions Dominated: Global
Medtronic is a key player in cardiovascular and neurovascular guidewire systems, especially in – Percutaneous coronary intervention (PCI), Peripheral vascular and endovascular procedures, Electrophysiology and Neurovascular navigation.
Popular Medtronic Guidewires:
Medtronic serves over 150 countries, maintaining a deep integration with hospitals, clinics, and training centers worldwide.
Medtronic has committed to — Pledged net zero emissions by 2045
Founded: 1888
Headquarters: Illinois, USA
Employees: Approx. 114,000
2024 Revenue: $40 Billion (total)
Regions Dominated: Global
Abbott is a top-tier manufacturer of interventional vascular devices, with a strong portfolio of coronary and peripheral guidewires designed for precision, flexibility, and clinical safety.
Key Products in Guidewire Technology:
Abbott’s wires are often used alongside their balloon catheters, stents, and imaging systems.
Abbott Laboratories has committed to — Carbon Neutrality by 2030 in core operations.
Founded: 1839
Headquarters: Melsungen, Germany
Employees: Approx. 65,000
2024 Revenue: $9.5 Billion
Regions Dominated: EU, Asia, Middle East
Braun is well known for its peripheral vascular access and intervention technologies, including a suite of guidewires designed for safe and accurate placement of Catheters,Sheaths, Dialysis systems, Central venous access devices and more
Prominent Products:
Braun’s guidewires are generally used in critical care, vascular access, nephrology, and interventional radiology.
Braun has committed to — Carbon-neutral by 2030 in Europe
Founded: 1971 (Cordis founded 1957)
Headquarters: Dublin, Ohio, USA
Employees: Approx. 46,000
2024 Revenue: $145 Billion (total), Approx. $1.5B medtech division
Regions Dominated: North America, LATAM
Although Cardinal Health sold Cordis to private equity firm Hellman & Friedman in 2021, Cordis remains closely associated with Cardinal through product distribution partnerships. It continues to lead in cardiovascular devices, especially guidewires and catheters. Key Guidewire Brands from Cordis:
These guidewires are commonly used in angiography, PCI, and peripheral interventions, often in tandem with Cordis' balloon catheters and stents.
Cardinal Health has committed to — Reducing Scope 1 and Scope 2 Emissions by 50% by 2030.
Founded: 1963
Headquarters: Bloomington, Indiana, USA
Employees: Approx. 12,000
2024 Revenue: $2.3 Billion
Regions Dominated: USA, EU, Australia
Cook Medical is widely respected for its specialty guidewires in vascular access, endourology, GI endoscopy, and critical care. Known for durability, support, and clinical versatility, Cook guidewires are used in complex and routine procedures alike.
Popular Guidewire Products:
Cook Medical has pledged to — Eliminate landfill waste by 2030.
Founded: 1919
Headquarters: Tokyo, Japan
Employees: Approx. 35,000
2024 Revenue: $6.8 Billion
Regions Dominated: Asia, North America
Olympus is not a broad provider of cardiovascular guidewires, but it is a global leader in endoscopic and gastrointestinal (GI) guidewires, crucial for procedures like ERCP (endoscopic retrograde cholangiopancreatography), stone retrieval, and stent placement.
Flagship GI & Endoscopic Guidewire Lines:
These guidewires are optimized for precision, control, and flexibility in tortuous anatomy such as the bile duct or ureters.
Olympus has committed to — Targeting Carbon Neutrality by 2030 in manufacturing.
Founded: 1987
Headquarters: South Jordan, Utah, USA
Employees: Approx. 7,000
2024 Revenue: $1.3 Billion
Regions Dominated: US, EU, APAC
Merit Medical Systems, Inc. is a global healthcare company that designs, manufactures, and distributes disposable medical devices (Guidewires) used in interventional, diagnostic, and therapeutic procedures.
Merit Medical provides high-precision guidewires used in Cardiovascular procedures, Peripheral interventions, Radiology and Oncology & Urology and Endoscopy.
Key Guidewire Products:
Launched Merit Zero Initiative to reduce greenhouse gas emissions and packaging waste
Regional Insights (2025 Outlook)
Region | Key Players | Growth Drivers |
North America | Boston Scientific, Abbott, Merit | Cardiac procedures, aging population |
Europe | B. Braun, Medtronic, Cook | Universal healthcare access |
Asia-Pacific | Terumo, Asahi Intecc, Olympus | Rapid urbanization, medical tourism |
LATAM & MEA | Cordis, Medtronic, Abbott | Emerging infrastructure, partnerships |
North America dominates the market as it has an uninterrupted health care structure, high health care expenditure, and practice of minimally invasive surgeries. Among all the markets, the United States dominated the market. The reasons are raising cases of cardiovascular diseases, a greater demand for precise surgical interventions, and major medical device manufacturers are located in the region. Other technologies that have contributed to its dominance include favourable regulatory conditions towards innovation in guidewires. Also, the Europe guidewires market is rapidly rising with Germany, France, and the United Kingdom on the high list. Among the most vital factors contributing to its growth in Europe is its aged population. Since the geriatric population is more prone to chronic diseases like cardiovascular, these patients require a higher number of interventions. Moreover, better medical technologies and a higher expenditure on healthcare services are increasing the utilization of advanced guidewire solutions.
The Asia-Pacific region is one of the strongest growth drivers of the guidewires market. The development pace of the region's healthcare infrastructure and growing disposable income along with an increased number of surgical procedures contribute to it.
The region is witnessing an increased demand for high-end medical devices due to improved access to health services and treatment in countries such as China, India, and Japan. Improved government health care facilities in the region, accelerating the prevalence of lifestyle diseases, further accelerate the growth of the region. Latin America and Middle East & Africa are emerging guidewires markets, primarily driven by improvements in healthcare infrastructure and growing awareness about the advantages of minimally invasive surgeries. Cost constraints and diverse health standards, however, are expected to challenge these regions and limit market potential in some geography.
Would you like me to add more details on specific companies or market trends? Let me know! CLICK HERE
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.
